WHO ICTRP trial
Phase 1 safety, tolerability, and pharmacokinetic study of Docetaxel…
CTRI/2010/091/001122 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2010/091/001122 |
|---|---|
| Public title | Phase 1 safety, tolerability, and pharmacokinetic study of Docetaxel nano-dispersion: A randomized, open label, dose ranging, active controlled, comparative, parallel groups, and multi-centric study. |
| Scientific title | Phase 1 safety, tolerability, and pharmacokinetic study of Docetaxel nano-dispersion: A randomized, open label, dose ranging, active controlled, comparative, parallel groups, and multi-centric study. |
| Primary sponsor | Sun Pharma Advanced Research Company Ltd |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 1 |
| Countries | India |
| Conditions | Health Condition 1: null- locally advanced or metastatic breast cancer, locally advanced non-small cell lung cancer, hormone refractory metastatic prostate cancer, other tumor type with no standard treatment |
| Interventions | Intervention1: Docetaxel injection concentrate for nano-dispersion (DICN): 1 Cycle Control Intervention1: Polysorbate 80 based Docetaxel formulation: 1 cycle |
| Registration date | Aug 9, 2010 |
| Target size | 30 |
| Secondary IDs | CLR_09_01 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: